{"id":5711,"date":"2022-06-15T11:46:57","date_gmt":"2022-06-15T11:46:57","guid":{"rendered":"https:\/\/grupo.us.es\/farmolap\/web\/beta\/?page_id=5711"},"modified":"2022-08-29T11:18:05","modified_gmt":"2022-08-29T11:18:05","slug":"contracts","status":"publish","type":"page","link":"https:\/\/grupo.us.es\/farmolap\/web\/en\/what-we-do\/contracts\/","title":{"rendered":"Contracts"},"content":{"rendered":"

Contracts<\/h1>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/section>
\n\n\n\n\n\n\n\n\n
\n

Start date<\/h4>\n<\/td>\n

\n

End date<\/h4>\n<\/td>\n

\n

Designation<\/h4>\n<\/td>\n

\n

Funding Agency<\/h4>\n<\/td>\n<\/tr>\n

1-2-2013<\/td>\n30-6-2013<\/td>\nEffects of an algal extract\/fruit oils on longevity and obesity phenotypes using the model organism Caenorhabditis elegans (ACRONYM POLINAT 2013) (1784\/0151).<\/a><\/td>\nPOLIFENOLES NATURALES, S.L. (POLINAT)<\/td>\n<\/tr>\n
1-1-2011<\/td>\n30-12-2011<\/td>\nEffects of the ptobiotic VSL 3 on experimental intestinal colitis-associated carcinogenesis\u00a0(1058\/0151)<\/a><\/td>\nActial Farmac\u00e9utica<\/td>\n<\/tr>\n
30-11-2009<\/td>\n30-6-2011<\/td>\nProduction and assessment of bimass from microalgae; Sub-project A-6-3. Study to obtain and evaluate natural products from waste biomass: pharmaceutical uses (0632\/0151).<\/a><\/td>\nBIOTECNOLOG\u00cdA DE MICROALGAS, S.L.<\/td>\n<\/tr>\n
1-10-2008<\/td>\n30-6-2009<\/td>\nStudy to obtain and recover biomass from microalgae (0245\/0151)<\/a><\/td>\nAurantia 2003, S.L.<\/td>\n<\/tr>\n
17-7-2002<\/td>\n18-12-2002<\/td>\nImmunohistochemical and molecular study of the regulatory factors of angiogenesis, proliferation and apoptosis in a model of experimental chronic ulcer (OG-121\/02).<\/a><\/td>\nZambon, S.A.<\/td>\n<\/tr>\n
1-12-2000<\/td>\n1-12-2001<\/td>\nEffects of ibuprofen – L-Arginine and Rocecoxib, the COX inhibitor on lesions previously induced in the rat chronically with hydrochloric acid (OG-007\/01).<\/a><\/td>\nZambon, S.A.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/section>\n","protected":false},"excerpt":{"rendered":"Contracts Start date End date Designation Funding Agency 1-2-2013 30-6-2013 Effects of an algal extract\/fruit oils on longevity and obesity phenotypes using the model organism Caenorhabditis elegans (ACRONYM POLINAT 2013) (1784\/0151). POLIFENOLES NATURALES, S.L. (POLINAT) 1-1-2011 30-12-2011 Effects of the ptobiotic VSL 3 on experimental intestinal colitis-associated carcinogenesis\u00a0(1058\/0151) Actial Farmac\u00e9utica 30-11-2009 30-6-2011 Production and assessment...","protected":false},"author":8,"featured_media":0,"parent":5339,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/grupo.us.es\/farmolap\/web\/wp-json\/wp\/v2\/pages\/5711"}],"collection":[{"href":"https:\/\/grupo.us.es\/farmolap\/web\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/grupo.us.es\/farmolap\/web\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/grupo.us.es\/farmolap\/web\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/grupo.us.es\/farmolap\/web\/wp-json\/wp\/v2\/comments?post=5711"}],"version-history":[{"count":6,"href":"https:\/\/grupo.us.es\/farmolap\/web\/wp-json\/wp\/v2\/pages\/5711\/revisions"}],"predecessor-version":[{"id":5813,"href":"https:\/\/grupo.us.es\/farmolap\/web\/wp-json\/wp\/v2\/pages\/5711\/revisions\/5813"}],"up":[{"embeddable":true,"href":"https:\/\/grupo.us.es\/farmolap\/web\/wp-json\/wp\/v2\/pages\/5339"}],"wp:attachment":[{"href":"https:\/\/grupo.us.es\/farmolap\/web\/wp-json\/wp\/v2\/media?parent=5711"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}